SYSTEM AND METHOD FOR COMMUNICATING WITH PHARMACEUTICAL CONSUMERS AND MANAGING DATA RELATED THERETO

• US 20150032463A1
• Filed: 07/24/2013
• Published: 01/29/2015
• Est. Priority Date: 07/23/2013
• Status: Abandoned Application

• Current Assignee: PharmaSecure Incorporated
• Original Assignee: PharmaSecure Incorporated
• Inventors: Pasricha, Nakul, Sigworth, Nathan J., Kunin, Jay S.
• Application Number:
  US13/950,265
• Publication Number:
  US 20150032463A1
• Time in Patent Office: Days
• US Class Current: 705/2
• CPC Class Codes: G06Q 30/0185 Product, service or business identity fraud
• CPC Class Codes: G16H 20/10 relating to drugs or medications, e.g. for ensuring correct administration to patients
• CPC Class Codes: G16H 80/00 ICT specially adapted for facilitating communication between medical practitioners or patients, e.g. for collaborative diagnosis, therapy or health monitoring
• CPC Class Codes: Y02A 90/10 Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Abstract

A system and method that includes communicating with a consumer, in response to receiving a request from the consumer to verify the authenticity of a product, to offer access to one or more services related to the product, receiving a selection by the consumer of at least one of the one or more services, sending a confirmation message to the consumer confirming the selection by the consumer of at least one of the one or more services and enabling the provision of the one or more service to the consumer.

Claims

1. A method comprising the steps of:

receiving a request from a consumer to verify authenticity of a product based upon a particular identification code associated with the product;

sending a communication to the consumer, in response to receiving the request from the consumer, to offer the consumer access to services related to the product;

receiving a selection by the consumer of one or more of the services;

sending a confirmation message to the consumer confirming the selection by the consumer of the one or more of the services; and

enabling access to the one or more of the services to the consumer.

2. The method as set forth in claim 1 wherein the request from the consumer is sent over a network comprising the Internet or a cellular telephone network.

3. The method as set forth in claim 1 wherein the services comprise dosage reminders, refill reminders, health tips, a health advisor or any other mHealth service or consumer interaction service.

4. The method as set forth in claim 1 further comprising mining data related to the one or more of the services accessed by the consumer.

5. The method as set forth in claim 1 further comprising enabling a doctor-patient communication-module that facilitates communication between the consumer and a doctor of the consumer.

6. A method comprising the steps of:

receiving data from a consumer, such that the data verifies an authenticity of a pharmaceutical product;

storing the data generated via consumer verification; and

mining the data generated via consumer verification to determine one or more attributes related to the use of the product.

7. The method as set forth in claim 6 wherein the data received from the consumer is stored and analyzed by interested third parties.

8. The method as set forth in claim 6 wherein the data received from the consumer is used for longitudinal consumer research studies.

10. The method as set forth in claim 6 further comprising enabling a doctor to directly call the consumer.

11. The method as set forth in claim 6 further comprising implementing a mobile DOTS program or other program to remotely monitor patient adherence to a prescribed course of medication

12. The method as set forth in claim 6 further comprising measuring sales fluctuations on a region-by-region basis.

13. The method as set forth in claim 6 further comprising:

providing a doctor with a doctor-patient communication card for distribution to a patient to thereby activate a doctor-patient communication module for communication between the doctor and the patient;

receiving a doctor-patient communication module code from the patient, requesting the doctor-patient communication module to be activated;

sending a confirmation communication to the patient, confirming enrollment in the program;

ascertaining preferences for services of the patient; and

providing services to the patient for a predetermined amount of time based upon the preferences for services of the patient.

14. The method as set forth in claim 13 wherein the confirmation communication comprises a text message, an electronic mail, a voicemail message, a social media-based message or other software-based interface.

15. The method as set forth in claim 13 wherein the doctor-patient communication card comprises a software-based electronic card.

16. The method as set forth in claim 13 wherein the doctor-patient communication card comprises a physical card having information displayed thereon.

9. The method as set forth in claim 9 wherein the longitudinal consumer research comprises measuring dropout rates, measuring patient health outcomes or measuring other changes in consumer behavior at predetermined intervals of 30 days, 60 days and 90 days as compared to initial use of the product.

17. A method comprising the steps of:

providing a user with a platform for services upon verification of one or more of a plurality of pharmaceutical products;

receiving consent from pharmaceutical manufacturer of the pharmaceutical product to combine services with the pharmaceutical product;

matching the user to one or more service providers that have been authenticated to the platform, based upon predetermined service provider-related criteria; and

providing services over the platform to the user.

18. The method as set forth in claim 17 wherein the predetermined service provider-related criteria comprise therapeutic area, geography or demographics.

19. The method as set forth in claim 17 wherein the services are provided over the platform by a third party with commercial considerations.